aspsirna2960 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna2960
siRNA Name: siSNCA_T2-9
Gene:Synuclein, alpha (SNCA)
Disease:Parkinsons disease (PD)
Wild allele/target (5'->3'): NA
Mutant allele/target (5'->3'):UAUGUGGAUACAAAUUCUC
Target Mutation: SNCA locus triplication
Wild siRNA (As strand):NA
ASP-siRNA (As strand):AUACACCUAUGUUUAAGAG
Mismatch position in siRNA: NA
Mutant allele (5'->3'): UAUGUGGAUACAAAUUCUC
ASP-siRNA (As strand):AUACACCUAUGUUUAAGAG
ASP-siRNA efficacy for mutant allele:55
Wild allele (5'->3'): NA
ASP-siRNA (As strand):AUACACCUAUGUUUAAGAG
ASP-siRNA efficacy for wild allele:15
Percentage discrimination for ASP-siRNA:40
Wild allele (5'->3'): NA
Wild siRNA (As strand):NA
Wild sirna efficacy for wild allele:NA
Wild allele (5'->3'): NA
ASP-siRNA (As strand):AUACACCUAUGUUUAAGAG
Wild sirna efficacy for mutant allele:NA
Percentage discrimination for wild siRNA:NA
Concentration:20 nmol
Orientation:Double strand
Mismatch in:siRNA
UniProt ID: P37840
Target sequence: TCGAGAGGATTTATGTGGATACAAATTCTCCTTTAAAGTGTTTCTTCCCTTAATATTTATCTGACTTACTAGT
Genbank Accesion: NM_001146055.1
Cell-line: HeLa
Experimental technique used: Dual luciferase reporter assay
Transfection method: Lipofectamine2000
siRNA expression method: Sigma-Aldrich
Post-transfection duration: 24 hours
OMID ID: 168600
KEGG disease ID:H00057
Reference:25965551

.
.
.
.
.
.
.
.
.
.
.

.

.

.